NL300754I2 - - Google Patents

Download PDF

Info

Publication number
NL300754I2
NL300754I2 NL300754C NL300754C NL300754I2 NL 300754 I2 NL300754 I2 NL 300754I2 NL 300754 C NL300754 C NL 300754C NL 300754 C NL300754 C NL 300754C NL 300754 I2 NL300754 I2 NL 300754I2
Authority
NL
Netherlands
Prior art keywords
cells
limbar
laminae
grafts
reconstructing
Prior art date
Application number
NL300754C
Other languages
English (en)
Dutch (nl)
Original Assignee
Holostem Terapie Avanzate Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Holostem Terapie Avanzate Srl filed Critical Holostem Terapie Avanzate Srl
Publication of NL300754I2 publication Critical patent/NL300754I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/56—Fibrin; Thrombin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Prostheses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NL300754C 2001-08-03 2015-07-23 NL300754I2 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001RM000476A ITRM20010476A1 (it) 2001-08-03 2001-08-03 Lamine di epitelio corneale umano ricostruite e metodo per il loro ottenimento.
PCT/IT2001/000603 WO2003012083A1 (en) 2001-08-03 2001-11-28 In vitro reconstituted sheets of human corneal epithelium and method of producing the same

Publications (1)

Publication Number Publication Date
NL300754I2 true NL300754I2 (enExample) 2016-09-01

Family

ID=11455714

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300754C NL300754I2 (enExample) 2001-08-03 2015-07-23

Country Status (12)

Country Link
US (1) US6610538B2 (enExample)
EP (1) EP1451302B1 (enExample)
AT (1) ATE397058T1 (enExample)
CY (1) CY1108257T1 (enExample)
DE (1) DE60134280D1 (enExample)
DK (1) DK1451302T3 (enExample)
ES (1) ES2307570T3 (enExample)
FR (1) FR15C0055I2 (enExample)
IT (1) ITRM20010476A1 (enExample)
NL (1) NL300754I2 (enExample)
PT (1) PT1451302E (enExample)
WO (1) WO2003012083A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050186672A1 (en) * 2004-01-27 2005-08-25 Reliance Life Sciences Pvt. Ltd. Tissue system with undifferentiated stem cells derived from corneal limbus
US8187875B2 (en) * 2004-02-26 2012-05-29 Reliance Life Sciences Pvt. Ltd. Dopaminergic neurons derived from corneal limbus, methods of isolation and uses thereof
KR100840979B1 (ko) * 2004-02-26 2008-06-24 리라이언스 라이프 사이언시스 프라이빗. 리미티드 각막 윤부에서 유도된 다능성 배아 유사 줄기 세포, 분리방법 및 이들의 용도
US20060216821A1 (en) * 2004-02-26 2006-09-28 Reliance Life Sciences Pvt. Ltd. Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof
ITRM20040273A1 (it) * 2004-06-03 2004-09-03 Farmigea Spa Metodo per l'isolamento e l'espansione ex vivo di cellule staminali corneali umane e loro relativi usi.
KR20080097226A (ko) * 2006-02-24 2008-11-04 리라이언스 라이프 사이언시스 프라이빗. 리미티드 결막 조직 시스템
WO2011040888A1 (en) * 2009-10-01 2011-04-07 Singapore Health Services Pte Ltd A biodegradable composition or combination and uses thereof
RU2505303C2 (ru) * 2011-09-13 2014-01-27 Общество с ограниченной ответственностью "Офтальмологические биотехнологии" Способ получения биотрансплантата для роговицы
FR2993282B1 (fr) 2012-07-13 2017-11-10 Expanscience Lab Procede d'identification de marqueurs moleculaires de la peau d'enfant
FR3011008B1 (fr) 2013-09-24 2017-12-29 Expanscience Lab Procedes d'evaluation des effets deleteres des uv sur la peau d'enfant
FR3016373B1 (fr) 2014-01-10 2018-01-19 Laboratoires Expanscience Modele de peau de mammelon reconstitue
FR3019186B1 (fr) 2014-03-31 2019-06-07 Laboratoires Expanscience Procedes d'evaluation des effets deleteres de l'urine sur la peau d'enfant
FR3045669B1 (fr) 2015-12-16 2019-04-05 Laboratoires Expanscience Procedes d'evaluation des effets de la deshydratation sur la peau d'enfant
FR3053053B1 (fr) 2016-06-23 2018-07-13 Laboratoires Expanscience Modeles de la dermatite atopique juvenile
FR3068045B1 (fr) 2017-06-22 2021-06-04 Expanscience Lab Modeles de peau sensible reconstituee
EP3867357B1 (en) * 2018-10-19 2024-09-25 Regents of the University of Minnesota Methods of isolating and using descemet's membrane and compositions including isolated descemet's membrane
FR3133198B1 (fr) 2022-03-04 2025-11-21 Pierre Fabre Dermo Cosmetique Modele de peau reconstituee
FR3138149A1 (fr) 2022-07-25 2024-01-26 Pierre Fabre Dermo-Cosmetique Méthode d’évaluation in vitro de l’activité photoprotectrice d’un actif

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255657B (it) 1992-05-29 1995-11-09 Colture di tessuto di mucosa congiuntivale differenziata, procedimentoper la loro preparazione e supporti per il loro uso.
US5827641A (en) 1992-11-13 1998-10-27 Parenteau; Nancy L. In vitro cornea equivalent model
CA2227827A1 (en) 1998-01-23 1999-07-23 Unknown In vitro artificial cornea and sclera

Also Published As

Publication number Publication date
ITRM20010476A0 (it) 2001-08-03
DE60134280D1 (de) 2008-07-10
EP1451302A1 (en) 2004-09-01
ES2307570T3 (es) 2008-12-01
US6610538B2 (en) 2003-08-26
PT1451302E (pt) 2008-09-08
ITRM20010476A1 (it) 2003-02-03
FR15C0055I2 (fr) 2016-06-24
US20030027333A1 (en) 2003-02-06
ATE397058T1 (de) 2008-06-15
DK1451302T3 (da) 2008-09-08
EP1451302B1 (en) 2008-05-28
FR15C0055I1 (enExample) 2015-09-11
CY1108257T1 (el) 2014-02-12
WO2003012083A1 (en) 2003-02-13

Similar Documents

Publication Publication Date Title
FR15C0055I1 (enExample)
WO2004070013A3 (en) Use of islet 1 as a marker for isolating or generating stem cells
AU2002319780A1 (en) Alternative compositions and methods for the culture of stem cells
AU2003295444A1 (en) Methods for in vitro expansion of hematopoietic stem cells
TWI255852B (en) Method and carrier for culturing multi-layer tissue in vitro
IL160188A0 (en) Materials and methods to promote repair of nerve tissue
EP1276486B8 (en) Joint repair using mesenchymal stem cells
EP2418271A3 (en) Methods and compositions for treatment of bone defects with placental cell populations
NZ603330A (en) Diagnosis and treatment of multiple sulfatase deficiency and other sulfatase deficiencies
SG170068A1 (en) Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
AU2001286202A1 (en) Method of culturing mesenchymal stem cells
IL162648A0 (en) Cellular compositions and methods of making and using them
EP1650307A3 (en) Methods for making recombinant proteins using apoptosis inhibitors
DE60216959D1 (de) Sich in schlagende kardiomyozyten verwandelnde stammzellen
AU2002316230A1 (en) Methods of culturing animal cells and polypeptide production in animal cells
AU2003304250A1 (en) Method of isolating cells from umbilical cord
AU2000233235A1 (en) Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
PT1379671E (pt) Métodos de cultura de circovírus
ATE376065T1 (de) Enzymatische herstellung urethangruppenhaltiger (meth)acrylsäureeester
AU2002348947A1 (en) Compositions and methods for amplification of human stem cells
AU2003280687A1 (en) Composition for culturing multipotent stem cells and utilization of the same
ATE445426T1 (de) Portsystem für einen perkutan implantierten port
AU2003250519A1 (en) Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures
SI1456238T1 (sl) Proizvodnja f(ab)2 fragmentov v sesalskih celicah
DK0793503T3 (da) Anvendelse af hepatocyt-vækstfaktor til inducering af profilerering og differentiering af hemotopoietiske celler